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Intestinal epithelial cells (IECs) detect bacterial and viral associated molecular patterns via
germline-encoded pattern-recognition receptors (PRRs) and are responsible for maintain-
ing immune tolerance to the communities of resident commensal bacteria while being
also capable to mount immune responses against pathogens.Toll-like receptors (TLRs) are
a major class of PRRs expressed on IECs and immune cells, which are involved in the
induction of both tolerance and inflammation. In the last decade, experimental and clinical
evidence was generated to support the application of probiotics with immunoregulatory
capacities (immunobiotics) for the prevention and treatment of several gastrointestinal
inflammatory disorders in whichTLRs exert a significant role.The majority of these studies
were performed in mouse and human cell lines, and despite the growing interest in the
bovine immune system due to the economic importance of cattle as livestock, only few
studies have been conducted on cattle. In this regard, our group has established a bovine
intestinal epithelial (BIE) cell line originally derived from fetal bovine intestinal epitheliocytes
and used this cell line to evaluate the impact of immunobiotics in TLR-mediated inflam-
mation. This review aims to summarize the current knowledge of the beneficial effects of
immunobiotics in the regulation of intestinal inflammation/infection in cattle. Especially, we
discuss the role of TLRs and their negative regulators in both the inflammatory response
and the beneficial effects of immunobiotics in bovine IECs.This review article emphasizes
the cellular and molecular interactions of immunobiotics with BIE cells through TLRs and
gives the scientific basis for the development of immunomodulatory feed for bovine healthy
development.
Keywords: immunobiotics,TLR4, intestinal immunity, inflammation, bovine intestinal epitheliocytes,TLR negative
regulators, lactobacilli, bifidobacteria
INTRODUCTION
Intestinal epithelial cells (IECs) are structurally and functionally
polarized. These cells have an apical surface facing the intestinal
lumen and a basolateral surface facing the underlying basement
membrane and the lamina propria. IECs provide a physical bar-
rier that separates commensal bacteria in the lumen from the
underlying lamina propria and deeper intestinal layers (1). In
addition, IECs are a central component of the immune sys-
tem of the gut. Over the last decades, great progress has been
achieved in understanding IECs immunobiology (2). It was amply
demonstrated that the cross-talk between the epithelium with gut
microbes significantly influences the activities of immune cells in
the mucosa (2). The detection of commensal bacteria, pathogens,
or probiotics by IECs is achieved through the families of germline-
encoded pattern-recognition receptors (PRRs) that recognize con-
served molecular structures known as microbe-associated molec-
ular patterns (MAMPs). MAMPs and PRRs interaction and the
subsequent signaling in IECs is involved in several important
mechanisms that are crucial for maintaining a healthy epithelial
barrier including maintenance of tight junctions strength, epithe-
lial cell proliferation and renewal, expression of antimicrobial
peptides, and modulation of mucosal immune responses (3).
In recent years, worldwide interest has rapidly and significantly
increased in the therapeutic and preventive effects of “friendly
bacteria.” These microorganisms, recognized as probiotics, are
generally selected from Lactobacilli or Bifidobacteria strains (4).
Several studies in animal models as well as clinical trials support a
unique role for probiotics by beneficially modulating the mucosal
immune system. Thus, a new term was required to identify pro-
biotic bacteria that promote health by regulating the mucosal
immune system. Clancy suggested the new term “immunobiotics”
as appropriate for fulfilling this need (5). The quest for a bet-
ter understanding of how immunobiotics works have led to an
enormous interest in the molecular processes underlying host–
microbe interactions. As reviewed by Lebeer et al. (6), the final
conclusion of works that have studied the molecular mechanism
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of probiotic immunomodulatory activities is that: “their effect
depends on the combination of distinct MAMPs that interact with
various PRRs and the associated co-receptors that fine tune signaling,
as well as on the quantity and quality of these MAMPs. Therefore,
host-immunobiotic interactions are not univocal but involve complex
interactions among various microbial molecules, host receptors, and
adaptor molecules” (6).
This expanding knowledge about the cellular and molecular
effects of beneficial bacteria in innate mucosal immune system
has raised the possibility of new treatments for improving health
not only in humans but also in animals. In this review, we
describe the recent advances in the impact of immunobiotics on
bovine intestinal epithelial (BIE) cells and possible novel thera-
peutic approaches to beneficially modulate bovine epithelial cell
immunobiology. Especially, we discuss the role of toll-like recep-
tors (TLRs), their signaling pathways, and their negative regula-
tors in both the inflammatory-intestinal injury and the beneficial
effects of immunobiotics. This article emphasizes the cellular and
molecular interactions of immunobiotics with bovine epithelial
cells through TLRs and gives the scientific basis for the future
development of immunomodulatory feed for improving bovine
health.
BOVINE INTESTINAL EPITHELIAL CELLS
The development of bovine intestinal cell cultures and their char-
acterization with regard to their permissiveness for bacterial adhe-
sion and invasion, and the ability to sense PAMPs through PRRs
represents an important step forward toward the establishment
of in vitro systems to study molecular interactions of patho-
genic, commensal, and probiotic microorganisms with the bovine
host (7).
For cattle, primary cultures of ileum or colon epithelial cells
have been used for toxicological assays, the study of microbial
virulence factors, the efficacy of antimicrobial compounds, and
the evaluation of innate immune responses through PRRs signal-
ing (7–12). A combination of the enzymatic digestion (dispase
and collagenase) together with soft mechanical agitation proved
to be a successful method for releasing intact, viable bovine colonic
crypts from underlying mesenchymal tissue. However, a series
of purification steps was required to eliminate the majority of
contaminating non-epithelial cells (mostly fibroblasts) from the
crypt suspension (10). Similarly, cultures of bovine colonocytes
and jejunocytes were obtained by Rusu et al. (11), using a combi-
nation of enzymatic and mechanical disruption of the intestinal
epithelium. The study showed that primary cultures of bovine
enterocytes isolated from colon and jejunum presented charac-
teristics of epithelial cells, such as a typical pavement-like aspect,
the formation of domes and apical tight junctions, and microvilli
in confluent cultures. Moreover, these bovine colonocytes and
jejunocytes expressed epithelial cell markers such as brush border
enzymes and the epithelium typical cytoskeleton proteins, such as
cytokeratins.
Dibb-Fuller et al. (8) developed primary bovine cell lines
from ileum, colon, and rectum and those bovine primary
gastrointestinal epithelial-derived cells were successfully used
to assess adherence and invasion of several intestinal path-
ogenic bacteria including enterohemorrhagic Escherichia coli
(EHEC) and Salmonella enterica serotype typhimurium. In addi-
tion, bovine colonic crypts cells isolated and purified from
the mucosa, proved to be useful in vitro tools to study vir-
ulence factors of EHEC, verotoxins, in particular (10). The
work showed the expression of globotriaosylceramide Gb3 by
bovine colonocytes, which directly contrasts with the absence
of this receptor on human intestinal epithelium. This fact rep-
resents a fundamental difference that could have major signifi-
cance in the different pathogenicity of EHEC in these hosts, and
make bovine colonocytes an invaluable tool for studying EHEC
infection (10).
Bridger et al. (7) showed that epithelioid cells from bovine
colonic crypts formed a confluent monolayer on the surface
of collagen-coated culture flasks. Those bovine colonocytes
expressed epithelial cell-specific cytokeratin and cell membrane-
associated tight junctional ZO-1 in the contact area between
neighboring cells. Semi-quantitative RT-PCR demonstrated vari-
able amounts of gene transcripts for different TLR genes. Notably,
primary bovine colonocytes expressed TLR4 mRNA while tran-
scripts for TLR1, TLR3, and TLR6 were also detectable in some
cultures. Moreover, the study showed that colonocytes significantly
up-regulated the expression of IL-8, MCP-1, and RANTES when
challenged with pathogenic E. coli or lipopolysaccharide (LPS)
(7). Therefore, short-term bovine colonocytes cultures proved to
be suitable in vitro models to study pathogens-specific responses
of the bovine colonic mucosa.
Those studies clearly demonstrated that bovine primary IEC
cultures represent valuable tools to assess the molecular mecha-
nisms involved in pathologies caused by infectious agents. How-
ever, the cellular and molecular interactions of commensal or
probiotic bacteria with BIE cells have been less explored.
There is an increasing research in the use of immunobiotics
to beneficially modulate the mucosal immune system in ani-
mals. Immunobiotic bacteria could be used for improving resis-
tance against pathogens and decreasing intestinal inflammatory-
mediated tissue damage (13–17). In this regard, our laboratories
and others’ have conducted in vitro and in vivo studies utiliz-
ing different lactobacilli and bifidobacteria strains to evaluate the
effect of immunobiotics against infections and inflammation in
animals, however, the majority of these studies were performed in
swine and only few in the cattle (13).
We hypothesized that a cell line of BIE cells could be a useful
in vitro model for the evaluation of the molecular interactions
between IECs and bovine pathogens. In addition, such system
would allow the selection of immunobiotic microorganisms and
the study of the mechanisms by which probiotic lactic acid bacteria
(LAB) functionally modulate bovine IECs. Therefore, in order to:
(a) understand the functional role of IECs in bovine mucosal host
defense and (b) select potential immunobiotic LAB strains that
may be used to beneficially modulate the inflammatory response
in bovine IECs; we have recently established an immortalized BIE
cell line (18). Monolayer cobblestone and epithelial-like morphol-
ogy is assumed by BIE cells when cultured, with close contact
between the cells. Moreover, scanning electron microscopy exam-
ination of BIE cell reveled that 3-days old cells have irregular
and slender microvilli-like structures on their surface and that
this structures increase in complexity as the cells grow (18). BIE
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cells undergoes over at least 40 passages with no detectable loss of
epithelial properties.
Expression of TLRs mRNA in BIE cells was evaluated by RT-
qPCR and it was demonstrated that all TLRs genes were expressed
in BIE cells (19). TLR1, 3, 4, and 6 were strongly expressed,
followed by TLR5, 8, 9, 10, 2, and 7. We were particularly inter-
ested in expression of TLR2 and TLR4 in BIE cells as the main
receptors detecting Gram(+) probiotic bacteria and Gram(−)
pathogens, respectively. Therefore, to confirm real-time PCR find-
ings, we further examined the expression of TLR2 and 4 proteins
in BIE cells using anti-TLRs antibodies that are able to cross-react
with bovine TLRs (19). Visualization of the immunofluorescence
staining confirmed the protein expression of TLR2 and 4 in BIE
cells (Figure 1A).
FIGURE 1 |Toll-like receptor 4 (TLR4) expression in bovine intestinal
epithelial epitheliocytes (BIE cells) (A). Upon recognition of
lipopolysaccharide (LPS), TLR4 dimerizes and initiates a signaling cascades
that include phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein
kinase (MAPK), and nuclear factor κB (NF-κB) pathways; and culminates in
the production of inflammatory mediators by BIE cells (B).
The inflammatory response triggered by BIE cells in the face of a
challenge with heat-stable enterotoxigenic E. coli (ETEC) MAMPs
was also evaluated. Upon pathogen binding to TLR4 complex, this
receptor recruits, through its short intracellular toll-interleukin-
1 receptor (TIR) domain, adaptor molecules, and kinases, thus
initiating a downstream signaling cascade that culminates in the
production and secretion of inflammatory mediators such as TNF-
α, IL-1β, IL-6, and IL-8 (Figure 1B). The ETEC 987P strain used
in our experiments does not express the TLR5-ligand flagellin,
and we demonstrated that the main molecule responsible for the
inflammatory response triggered by this bacterium is the LPS (15,
16). Stimulation of BIE cells with heat-stable ETEC MAMPs from
strain 987P enhanced the production of the pro-inflammatory
cytokines IL-6, IL-8, IL-1β, and MCP-1 by activating mitogen-
activated protein kinase (MAPK) and nuclear factor κB (NF-κB)
pathways (19). These findings are in line with our previous reports
demonstrating that the heat-killed ETEC 987P strain triggers
a TLR4-mediated inflammatory response in porcine intestinal
epithelial (PIE) cells through NF-κB and MAPK pathways (20).
In addition, our results in BIE cells correlate with studies of the
immune response against ETEC in IECs of different hosts’ species.
It was shown that both NF-κB and MAPK pathways are important
mediators of ETEC and LPS activation in human (HT-29 and T84)
and mouse (CMT93) IECs (15, 21).
Available lines of evidence indicate that bovine epithelial
cells, including intestinal, mammary, bronchial, and nasopharynx
epithelial cells respond to bacterial LPS and other microbial prod-
ucts by producing pro-inflammatory cytokines required to combat
invading pathogens. Therefore, the pro-inflammatory mediators
produced by BIE cells in response to ETEC may have an impor-
tant protective role during the course of intestinal infections. The
chemokine IL-8 stimulates a strong infiltration of neutrophils in
the gut lamina propria, a fact that is consistently observed upon
ETEC infection. After IL-8 induced recruitment of neutrophils,
increase of IL-6 production is able to induce degranulation of
these cells, thereby enhancing the inflammatory response (22).
In addition, IECs are able to produce MCP-1 in response to
ETEC challenge. This chemokine has potent monocyte-activating
and attracting properties and plays a major role during intestinal
inflammation (23). Therefore, BIE cells respond to the presences
of ETEC and LPS by activating the TLR4-signaling pathway, which
is necessary to initiate a robust defensive action against intruders.
Our studies indicate then that the BIE cell line could be a useful
cell line for evaluating inflammatory responses via TLR4 in vitro.
Furthermore, considering that inflammatory responses induced
by intestinal pathogens can lead to dysregulation of IECs signal-
ing, disruption of membrane barrier integrity, enhancement of
pathogen translocation and disease (24), BIE cells could be also
used to evaluate therapies designed for preventing inflammatory
damage caused by bovine intestinal pathogens or their associated
PAMPs or virulence factors.
PROBIOTICS FOR THE BOVINE HOST
Several studies on the pathogenesis of intestinal inflamma-
tion/infection both in man and experimental animals continue to
show the importance of commensal bacteria in the gastrointestinal
tract in stimulating and directing the immune system. Moreover,
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the ability of immunobiotic bacteria to beneficially modulate
the response against intestinal pathogens in animals through the
improvement of resistance and the reduction of inflammatory-
mediated tissue damage has been described by several reports
(25–27). Before weaning, dairy calves are highly susceptible to
several pathogens. For several years, antibiotics have been used to
overcome these problems also to obtain economic benefits in terms
of improved calves performance and reduced medication costs.
However, the use of antibiotics in animal husbandry is in question
because of antibiotic resistance of microorganisms. In an effort
to replace antibiotics from bovine feeds, many additives have been
proposed including the use of probiotics (28, 29). In fact, some few
studies have shown that probiotic bacteria can be used as growth
promoters in calves instead of antibiotics to counteract the nega-
tive effects of their widespread use (30). Early studies of Abe et al.
(31) showed that oral administration of Bifidobacterium pseudo-
longum or Lactobacillus acidophilus to calves improved body weigh
gain and decreased the frequency of diarrhea occurrence. Simi-
larly, Mokhber-Dezfouli et al. (32) demonstrated that probiotic
treatments have the ability to beneficially modulate body weight
gain, body height, and general health condition of calves. Addi-
tionally, oral treatment with probiotic E. coli significantly reduced
the pathogenicity and fecal shedding of EHEC in calves (33, 34).
It was also reported that a mixture composed of Lactobacillus casei
DSPV 318T, Lactobacillus salivarius DSPV 315T, and Pediococcus
acidilactici DSPV 006T protected calves against Salmonella Dublin
infection (35). These studies clearly show the potential of probi-
otic bacteria to beneficially modulate gastrointestinal hemostasis
in the bovine host. However, the cellular and molecular mecha-
nisms involved in the probiotic activities in cattle have not been
studied in depth.
REGULATION OF INFLAMMATION IN BIE CELLS BY
IMMUNOBIOTIC LACTOBACILLI
The first contact of immunobiotic bacteria with the intestinal
mucosa is mediated by the single cell layer of IECs. As men-
tioned before, these IECs are of paramount importance in host–
immunobiotic cross-talk. Then, we thus sought to determine
whether an immunobiotic Lactobacillus strain could regulate the
inflammatory response induced by heat-stable ETEC MAMPs in
BIE cells. Our previous studies with the strain Lactobacillus jensenii
TL2937 showed that this bacterium has remarkable immunomod-
ulatory effects in porcine IECs and immune cells [for a review
see Ref. (3)]. The TL2937 strain is able to functionally mod-
ulate porcine IECs by inhibiting excessive MAPK- and NF-κB-
induced pro-inflammatory cytokine production (IL-6 and IL-8) in
response to TLR4 activation (3, 15). Consequently, we first focused
on L. jensenii TL2937 to evaluate its anti-inflammatory effect in
BIE cells. Preincubation of BIE cells with L. jensenii TL2937 sig-
nificantly decreased IL-6 and IL-8 expressions in 20 and 25% with
respect to the control, respectively, after heat-stable ETEC MAMPs
challenge (19). However, this effect was lower when compared with
the anti-inflammatory activity of this strain in PIE cells (15). In
porcine, IECs previously treated with the TL2937 strain, stimula-
tion with heat-stable ETEC MAMPs reduced IL-6 and IL-8 expres-
sions by 35 and 30% when compared to control cells, respectively
(15). Although the effect of the L. jensenii TL2937 in BIE cells was
lower than the one previously reported for porcine IECs, our first
studies in BIE cells indicated that probiotic lactobacilli could be
beneficial for attenuating inflammatory damage caused by TLR4
activation in bovine epithelial cells (19). Thus, we next aimed
to screen and select the most effective immunoregulatory lacto-
bacilli strains able to modulate TLR4-mediated pro-inflammatory
response in BIE cells. Several lactobacilli strains were evaluated
in our bovine IECs line and we found that some of these bacte-
ria were capable to downregulate the expression of inflammatory
cytokines. Among these strains, L. casei OLL2768 showed the most
pronounced effect (19). Notably, the anti-inflammatory activity of
the OLL2768 strain was more pronounced than that observed for
L. jensenii TL2937 in BIE cells, while the effect of OLL2768 strain
was lower in PIE cells (15). It is well known that probiotic activi-
ties are strain specific. In addition, our findings clearly indicated
that is necessary to carefully evaluate different strains according
to the specific host, because the effect of the same Lactobacillus
may be different according to the host that consumes it. Then, our
in vitro bovine system could be of great value to find potential
immunobiotic strains suitable for the improvement of the bovine
host health.
We also aimed to define the molecular mechanisms by which
L. casei OLL2768 attenuated heat-stable ETEC MAMPs-induced
pro-inflammatory response in BIE cells. Our data showed that the
immunoregulatory effect was related to the capacity of OLL2768
strain to inhibit NF-κB and MAPK p38 signaling pathways in
bovine IECs after TLR4 activation.
Nuclear factor κB is composed of several protein subunits reg-
ulating DNA transcription. Under non-stimulatory conditions, it
is bound to the inhibitor molecule IkB in the cytoplasm. After
TLR activation IkB is phosphorylated by IKK and once freed from
IkB, NF-κB subunit p65 (RelA) migrates into the nucleus, where
it binds to target promoters and activates transcription of effector
genes including TNF-α, IL-8, and others (36, 37). Among many
up-stream signaling proteins involved in NF-κB activation, TLR4
plays a critical role and it is well-documented that TLR4/NF-κB
pathway has a pivotal role in the pathogenesis of several intesti-
nal inflammatory diseases and infection-induced tissue damage
(38). Some studies have reported the ability of probiotic lacto-
bacilli to modulate TLR4/NF-κB pathway in the gut (39, 40). It
was showed that Lactobacillus suntoryeus, a gut commensal, blocks
inflammatory mediators (Cox2, TNF-α, IL-1, and IL-6) through
suppression of TLR4-linked NF-κB activation in mice with 2,4,6-
trinitrobenzene sulfonic acid-induced colitis (41). Liu et al. (42)
reported that Lactobacillus reuteri strains DSM 17938 and ATC-
CPTA4659 led to decrease intestinal protein levels of TLR4 and
decreased pro-inflammatory cytokine levels in parallel with inhi-
bition of TLR4-signaling via the NF-κB pathway in newborn rats
with necrotizing enterocolitis. In addition, it was reported that
some probiotics strains are able to suppress TNF- or Salmonella
typhimurium-induced IL-8 gene expression and secretion by IECs
in a NF-κB-dependent manner (39, 40). Our experiments also
demonstrated that L. casei OLL2768 is able to inhibit TLR4/p38
signaling pathway since we demonstrated that in lactobacilli-
treated BIE cells the phosphorylation of p38 was reduced after
challenge in heat-stable ETEC MAMPs (19). Regulation of MAPK
p38 pathway by probiotics has been described before. L. rhamnosus
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GG was found to significantly down-regulate expression of p38 in
human monocyte-derived DCs after the challenge with LPS (43).
It was also showed that Lactobacillus bulgaricus LBG, inhibited the
activation of the TLR4-signaling pathway and IL-8 production
induced by Helicobacter pylori LPS in human gastric adenocarci-
noma cells through blocking MAPK p38 (44). Then, our findings
in BIE cells are reminiscent of other studies showing that probi-
otic L. casei OLL2768 is capable of modulating TLR4/NF-κB- and
TLR4/p38-induced inflammation.
The JNK and p38 MAPK pathways share several up-stream
regulators, and accordingly there are multiple stimuli that simul-
taneously activate both pathways. In this regard, it was showed that
the conditioned media from probiotic L. rhamnosus GG induced
the expression of cellular heat shock protein (Hsp72) in IECs in
a p38- and JNK-dependent manner (45). The work showed that
L. rhamnosus GG conditioned media treatment resulted in a clear
activation of both p38 and JNK pathways in IECs. Moreover, expo-
sure of IECs to inhibitors against p38 and JNK before conditioned
media treatment resulted in blockade of Hsp72 expression, thus,
confirming a likely role for both MAPK signaling pathways in the
probiotic effect (45). Then, we expected that L. casei OLL2768
had an inhibitory effect on JNK pathway in BIE cells as observed
for the p38 MAPK pathway. However, increased levels of p-JNK
were detected in BIE cells stimulated with the OLL2768 strain. It
was also reported that JNK and p38 MAPK pathways may induce
opposite effects. In fact, there is evidence indicating that the p38
MAPK pathway can negatively regulate JNK activity in several
contexts (46, 47). The first evidence of the interaction of these
two pathways was the observation that inhibition of p38 strongly
increased the activation of JNK (46). The work analyzed the effect
of specific p38 MAPK inhibitors, SB202190 or SB203580, on JNK
phosphorylation in A549 human lung alveolar epithelial cells, and
found that inhibition of p38 MAPK could induce JNK activa-
tion due to a compensatory mechanism (46). In addition, it was
showed that the p38 inhibitor SB203580 enhances the activation
of JNK isoforms after the challenge of IECs with IL-1β or by LPS in
macrophages (46). In line with those studies, the kinetic analysis
of p38 and JNK phosphorylation in BIE cells showed an early up-
regulation of p–p38 between 5 and 10 min after heat-stable ETEC
MAMPs challenge that was followed by a down-regulation of p-
JNK between 10 and 20 min (19). Therefore, we can speculate that
L. casei OLL2768 has a direct influence in p38 pathway while its
effect in JNK is the result of the inhibition of p38 phosphorylation.
Further research is needed to clarify completely the influence of L.
casei OLL2768 in MAPK pathways in BIE cells.
Following TLR activation, there must be a checkpoint where
TLR signaling is abolished and the system is returned to a normal
physiological state to avoid a harmful response toward the host
immune system. Regulatory factors able to modulate the duration
and intensity of TLRs signals are therefore key components for
the protection of the hosts (48). Several regulatory mechanisms
have been described for TLRs including soluble and decoy factors,
membrane-associated protein regulators, negative regulators of
the adaptor complex, and microRNA (3). To assess the expression
of these negative regulators of TLRs, we first cloned cDNAs corre-
sponding to these proteins in the bovine (19). We demonstrated
the expression of A20-binding inhibitor of nuclear factor kappa B
activation 3 (ABIN-3); B-cell lymphoma 3-encoded protein (Bcl-
3); interleukin-1 receptor-associated kinase M (IRAK-M); single
immunoglobulin IL-1-related receptor (SIGIRR); toll interacting
protein (Tollip); and mitogen-activated protein kinase 1 (MKP-1)
in BIE cells (19). Consequently, the effect of L. casei OLL2768 on
the expression of these negative regulators of the TLRs signaling
was next evaluated. L. casei OLL2768 is able to up-regulate Tol-
lip and Bcl-3 in BIE cells, and in this way to negatively regulate
TLR4 signaling (19). Tollip is able to suppress the activity of IL-
1 receptor-associated kinase (IRAK), and inhibit TLR4-triggered
NF-κB and MAPK signaling pathways (49, 50). It was showed that
stimulation of IECs with a TLR ligand, such as LPS, induces a state
of hyporesponsiveness through up-regulation of Tollip that lim-
its pro-inflammatory responses triggered by a second challenge
with the same or another TLR ligand (50). The expression of Tol-
lip was reported in bovine mammary epithelial cells (51). The
work showed that expression of Tollip was increased in response
to LPS, suggesting that the bovine mammary epithelium possesses
the necessary immune repertoires required to regulate TLR4 acti-
vation. Recently, it was demonstrated by Fu et al. (52) that Tollip is
significantly up-regulated in bovine endometrial epithelial cells
after the stimulation with LPS, and that this up-regulation of
Tollip was necessary for the regulation of the overexpression of
NF-κB and the protection against the inflammatory damage. On
the other hand, the Bcl-3 is a nuclear protein and member of the
NF-κB family. Bcl-3 is able to stabilize repressive NF-κB homod-
imers in a DNA-bound state, and in this way prevents the binding
of transcriptionally active dimers. Therefore, Bcl-3 functions as
an inhibitor of NF-κB activity. In recent years, a role of Bcl-3 has
been revealed in LPS tolerance via its ability to stabilize the p50
homodimer, and thus, has been identified as a negative regulator
of TLR4 signaling (53). Furthermore, by selectively affecting chro-
matin remodeling, Bcl-3 mediates repression of pro-inflammatory
genes, and also facilitates the expression of the anti-inflammatory
gene IL-10 (54). Therefore, the induction of Bcl-3 and Tollip by L.
casei OLL2768 in BIE cells is important in establishing tolerance
against heat-stable ETEC MAMPs.
It is not possible to give a precise molecular mechanism for
the anti-inflammatory action of L. casei OLL2768 on BIE cells
at present. However, it could be hypothesized that interaction
of L. casei OLL2768 with BIE cells through one or more PRRs
induces the up-regulation of the negative regulators Bcl-3 and
Tollip, which reduce the production of inflammatory mediators
in response to heat-stable ETEC MAMPs (Figure 2). One of the
possible PRR involved in L. casei OLL2768 immunoregulatory
capacities could be TLR2. Studies with the TLR2 ligand Pam3CSK4
in BIE cells demonstrated that the treatment with the TLR2 ago-
nist up-regulate the expression of Tollip and reduce activation of
NF-κB and p38 MAPK pathways (19). However, further research
is needed to resolve which PRR is activated by L. casei OLL2768
for the induction of negative regulators.
REGULATION OF INFLAMMATION IN BIE CELLS BY
IMMUNOBIOTIC BIFIDOBACTERIA
Members of the genus Bifidobacterium are considered to be impor-
tant constituents of the microbiota of animals, from insects to
mammals. They are gut commensals extensively used by the
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FIGURE 2 | Modulation of toll-like receptor 4 (TLR4) signaling pathway
by Lactobacillus casei OLL2768, Bifidobacterium adolescentis MCC-75,
and Bifidobacterium adolescentis ATCC15705 in bovine intestinal
epithelial epitheliocytes (BIE cells). Anti-inflammatory immunobiotic strains
up-regulate the expression of TLR negative regulators, reduce the activation
phosphatidylinositol 3-kinase (PI3K), mitogen-activated protein kinase
(MAPK), and nuclear factor κB (NF-κB) pathways; and diminish the production
of inflammatory mediators by BIE cells.
food industry as probiotic microorganisms, since some strains
have been shown to have specific beneficial effects. Bifidobacte-
ria are able to prevent or alleviate infectious diarrhea through
their effects on the immune system and resistance to colo-
nization by pathogens. In addition, some bifidobacteria strains
have potent anti-inflammatory capacities that could be used to
reduce inflammatory-intestinal damage. Bifidobacterium animalis
strain AHC7 decrease NF-κB activation in mice infected with
S. typhimurium. B. animalis AHC7 consumption in this mouse
model was associated with protection against inflammatory dam-
age through modulation of secreted IL-10 and IL-12p70 and
enhancement of Foxp3 expression in naïve T cells (55). In line with
these results, it was showed that Bifidobacterium bifidum W23 was
able to induce a suppression of IL-8 synthesis by Caco-2 cells chal-
lenged with S. enterica serovar enteritidis, and that the protective
role of this probiotic strain was mediated, at least in part, via Hsp70
expression (56). Moreover, it was recently reported that Bifidobac-
terium adolescentis FRP 61, Bifidobacterium longum FRP 68 and
FRP 69, and Bifidobacterium breve FRP 334 significantly reduced
IL-8 production by HT-29 cells challenged with S. typhimurium
(57). Others studies evaluating the effect of bifidobacteria in
intestinal Caco-2 cells showed that B. animalis MB5 avoid cytokine
deregulation upon ETEC challenge by inducing upregulation of
IL-1β and TNF-α, and the down-regulation of TGF-β expression
(58, 59). Additionally, we demonstrated in porcine IECs cells that
treatment with B. breve MCC-117 significantly reduced the expres-
sion of inflammatory cytokines in response to heat-stable ETEC
MAMPs. Moreover, studies with porcine immune cells showed
that B. breve MCC-117 was able to reduce the levels of IFN-
γ in CD4+ and CD8+ lymphocytes and improved IL-10 levels
in CD4+CD25highFoxp3+ lymphocytes (14). These are among
several other studies that clearly showed that bifidobacteria are
highly effective in regulating pathogenic inflammation in the gut.
Therefore, we next aimed to select potential immunomodula-
tory bifidobacteria able to beneficially modulate the inflammatory
response in BIE cells.
The potential use of bifidobacteria as probiotic for cattle is
supported by some new reports indicating the presence of these
bacteria in young calf intestines and the fact that their presence
in high numbers is associated with good health status of the host
(60). Therefore, some bifidobacteria strains, previously selected in
our porcine systems, were used to evaluate their anti-inflammatory
capacities in heat-stable ETEC MAMPs-challenged-BIE cells (61).
Similarly to the effect of L. casei OLL2768, some bifidobacteria
were able to reduce the production of inflammatory mediators
triggered by TLR4 activation in BIE cells. Considering their abil-
ity to reduce the expression of IL-6 and MCP-1, bifidobacteria
strains were divided in the following two groups: (1) strains able
to reduce both IL-6 and MCP-1 (B. adolescentis MCC-75 and
B. breve MCC-117) and (2) strains able to reduce only IL-6 (B.
longum BB536, B. adolescentis ATCC15705 and Bifidobacterium
infantis MCC-1021) (61).
As described for the immunoregulatory L. casei OLL2768
strain, we also aimed to evaluate signaling pathways and TLR
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negative regulators expression in BIE cells after the treatment with
bifidobacteria belonging to the two functional groups defined by
our studies. Then, we selected B. adolescentis MCC-75, B. breve
MCC-117 (strains with high anti-inflammatory capacities), and B.
adolescentis ATCC15705 (strain with moderate anti-inflammatory
capacity) for further experiments. Activation of MAPK, NF-κB,
and phosphatidylinositol 3-kinase (PI3K) pathways, and changes
in the expression of TLR negative regulators in MCC-75-, MCC-
117- and ATCC15705-treated BIE cells were then studied. We
found that each bifidobacteria strain induces unique changes in
TLR4 signaling in bovine IECs (61) (Figure 2).
As mentioned before, several negative regulatory mecha-
nisms control TLRs-mediated inflammatory responses and restore
immune system balance in the gut. Although the NF-κB-
dependent gene expression is critical to the induction of an effi-
cient immune response, excessive, or prolonged NF-κB signaling
can contribute to the development of several inflammatory dis-
eases. Therefore, this signaling transduction pathway has to be
tightly regulated by several intracellular proteins. The ubiquitin-
editing enzyme A20 is key regulator of the TLRs signaling. It was
showed that A20 deficiency in IECs renders mice sensitive to TNF-
α-induced lethal inflammation (62, 63). Moreover, it was reported
that A20 is an early response negative regulator of TLR4 and TLR5
signaling in IECs that functions during intestinal inflammation
to control the innate immune system (64). In addition, the A20-
binding inhibitor of NF-κB activation (ABIN) is LPS-inducible
proteins that negatively regulate NF-κB activation in response to
TNF-α and LPS (65). ABINs have been described as three differ-
ent proteins (ABIN-1, -2, and -3) that bind A20. Overexpression
of ABINs inhibits NF-κB activation by TNF-α and several other
stimuli. Similar to A20, ABIN-3 expression is NF-κB dependent,
implicating a potential role for the A20/ABIN complex in the neg-
ative feedback regulation of NF-κB activation (66). Therefore, the
induction of A20/ABIN complex by bifidobacteria in BIE cells
is important in establishing tolerance against heat-stable ETEC
MAMPs. This is in line with our previous reports in porcine IECs.
In our works in the porcine systems, we showed that the bifi-
dobacteria strains with the highest capacity to downregulate the
expression of inflammatory cytokines in response to heat-stable
ETEC PAMPs were also able to up-regulate A20. In fact, the most
potent anti-inflammatory bacteria evaluated in our laboratory,
bifidobacteria strains BB536 and M-16V and L. jensenii TL2937,
strongly up-regulated the ubiquitin-editing enzyme A20 [for a
review see Ref. (3)].
Bcl-3 protein functions as an inhibitor of NF-κB activity as
mentioned before. In addition, SIGIRR, Tollip, and IRAK-M are
also known to be expressed at high levels in IECs, and to thereby
contribute to the hyporesponsiveness of IECs to commensals (64,
67, 68). Therefore, induction of these five negative regulators by
bifidobacteria in BIE cells may be important for establishing tol-
erance against heat-stable ETEC MAMPs (Figure 2). Moreover,
the fold expression increase of the negative regulators of the TLRs
signaling should be also important since the levels of ABIN-3,
IRAK-M, and Bcl-3 were significantly higher in B. breve MCC-
117- and B. adolescentis MCC-75-treated BIE cells when compared
with BIE cells treated with the moderate anti-inflammatory strain
B. adolescentis ATCC15705 (61).
On the other hand, the MAPK pathway is involved in the upreg-
ulation of several inflammatory genes, and MKP-1 plays a role in
the inhibition of pro-inflammatory mRNA expression, because it
can inactivate MAPK pathway (69). Therefore, we expected that
bifidobacteria with high anti-inflammatory activity significantly
up-regulate MKP-1 expression and reduce MAPK activation as
we have observed with other anti-inflammatory immunobiotic
strains (3). However, when ERK, p38, and JNK MAPK activation
and MKP-1 expression were studied in BIE cells treated with bifi-
dobacteria, we found that B. adolescentis MCC-75 and B. breve
MCC-117 activated ERK MAPK pathway and only moderately
up-regulated MKP-1. On the contrary, B. adolescentis ATCC15705
strongly increased expression of MKP-1 and inhibit p38 and JNK
pathways (61). It is known that the ERK pathway play key reg-
ulatory functions in a diverse spectrum of biological processes
such as cell proliferation, differentiation, survival, and motility
(70). It was also reported that TGF-β induces ERK activity in
IECs and this TGF-β/ERK interaction regulates genes that are
crucial for cell growth, migration, and survival of IECs (71, 72).
In fact, treatment with TGF-β prevents mucosal-injury, enhances
p-ERK and β-catenin, induces enterocyte proliferation, inhibits
enterocyte apoptosis, and improves intestinal recovery following
methotrexate-induced intestinal-mucositis in rats (73). More-
over, TGF-β increases protein levels, collagen I, TGF-β of type-1
inhibitor of plasminogen activator, and the TGF-β-converting
enzyme furin in various IEC lines via ERK (74) indicating an
important immunoregulatory role of the ERK pathway in main-
taining homeostasis in IECs. Therefore, the activation of the ERK
pathway by B. adolescentis MCC-75 and B. breve MCC-117 during
ETEC MAMPs-mediated inflammation could have an important
protective role against inflammatory damage (61).
Our studies also demonstrated that both B. adolescentis MCC-
75 and B. breve MCC-117 were able to inhibit PI3K pathway in
heat-stable ETEC MAMPs-challenged-BIE cells. It is known that
PI3K regulates TLR signaling in both positive and negative ways.
By mutating specific tyrosine residues in the cytosolic domain of
TLR2, it was showed that there is a loss in the capacity of p85 to
associate with this receptor and in the ability of TLR2 to activate
NF-κB pathway. Furthermore, inhibition of PI3K during TLR2
stimulation has been shown to reduce NF-κB activation (75).
On the contrary, studies in PI3K or p85a deficient mice showed
that PI3K negatively regulates TLR signaling (76, 77). Then, it
is well established that PI3K could affect TLRs signaling path-
ways in different ways and that it effect depends on cell type and
readout. In our studies, we showed that stimulation of BIE cells
with heat-stable ETEC MAMPs activated PI3K pathway, indicat-
ing that PI3K is positively involved in TLR4 signaling in BIE cells
(Figure 1B). Moreover, we demonstrated that bifidobacteria able
to reduce activation PI3K pathway were the strains with the highest
anti-inflammatory activity (61) (Figure 2).
As mentioned before, our works evaluating the immunoregu-
latory activity of immunobiotics demonstrated that the upreg-
ulation of some regulatory cytokines and down-regulation of
inflammatory mediators is dependent of TLR2 activation (15,
16). Therefore, we also investigated the role of TLR2 in the
immunoregulatory effects of B. adolescentis MCC-75, B. breve
MCC-117, and B. adolescentis ATCC15705 by using anti-TLR2
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blocking antibodies (61). It was showed that the reduction of IL-6
induced by bifidobacteria in ETEC MAMPs-challenged-BIE cells
was abolished when anti-TLR2 antibodies were used. This is in line
with other reports conferring a key role to TLR2 in the recognition
of bifidobacteria, which possess anti-inflammatory activities (78–
80). It is known that stimulation of TLR2 is able to induce tolerance
against a subsequent LPS challenge (81). Therefore, it is possible
that bifidobacteria could induce this type of cross-tolerance in
BIE cells through their interaction with TLR2. In addition, we
showed that the reduction of MCP-1 levels after challenge of BIE
cells was not abolished when anti-TLR2 antibodies were used.
This finding indicates that additional PRRs may be involved in the
anti-inflammatory effects of B. adolescentis MCC-75, and B. breve
MCC-117 in BIE cells.
CONCLUSION
The knowledge of the cellular and molecular interactions of
human IECs with commensal and probiotic bacteria is rapidly
progressing. An exciting possibility is that similar systems devel-
oped for the bovine host could serve as a platform for medicine and
research. However, to achieve this goal, bovine IECs cultures must
be enhanced and improved to allow that functional assays can be
performed. Our research work has demonstrated that the BIE cell
line is a useful in vitro tool for the study of TLR4-induced inflam-
matory responses in the bovine intestinal epithelium. We have also
demonstrated that BIE cells could be used for a rapid screening
and selection of potential immunobiotic bacteria as well as for
studying the molecular mechanisms involved in their beneficial
protective activity.
Despite the unique effect of each lactobacilli or bifidobacteria
strain, some general conclusions can be made when compar-
ing the effect of the two different immunoregulatory groups:
high anti-inflammatory activity (L. casei OLL2768, B. adoles-
centis MCC-75, and B. breve MCC-117) and moderate anti-
inflammatory activity (B. adolescentis ATCC15705) (Figure 2):
(1) anti-inflammatory capacity in BIE cells is strain dependent,
as demonstrated by the differential effect induced by each strain,
even those of the same specie (B. adolescentis MCC-75 and B.
adolescentis ATCC15705). (2) The upregulation of TLR negative
regulators and the intensity of that upregulation would be related
to the different immunomodulatory capacity of each immunobi-
otic strain. Notably, upregulation of Tollip and Bcl-3 seems to be
related to a high anti-inflammatory capacity. (3) The inhibition
of PI3K pathway would be related to the high anti-inflammatory
effect of immunobiotics in BIE cells. (4) The balance between
MAPK activation and MKP-1 upregulation would be related to
the anti-inflammatory effect of bifidobacteria in BIE cells. (5) The
anti-inflammatory effect of immunobiotics in BIE cells is partially
dependent on TLR2. Further research is needed to resolve which
other PRR is involved in the immunoregulatory effects. In addi-
tion, one general conclusion can be made when comparing the
effect of the two different immunoregulatory groups of bifidobac-
teria (Figure 2). (6) The upregulation of IRAK-M and ABIN-3 and
the intensity of that upregulation would be related to the different
immunomodulatory capacity of each bifidobacteria strain.
We believe that studies in BIE cell would provide useful infor-
mation that may help in the near future to develop new functional
feeds able to beneficially modulate the mucosal immune system in
the bovine host. In line with this, we showed in our studies that the
immunoregulatory strains L. casei OLL2768, B. adolescentis MCC-
75, and B. breve MCC-117 are able to functionally modulate BIE
cells by attenuating TLR4-induced NF-κB, MAPK, and IP3K acti-
vation and inflammatory cytokines production. Then, OLL2768,
MCC-75, and MCC-117 strains would be good candidates for
in vivo evaluation of the protective effect of immunobiotics against
inflammatory damage induced by bovine intestinal pathogens or
their associated PAMPs. We also believe that the immunobiotic
application in cattle could contribute to produce safety animal
foods via improving bovine health.
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